Back

A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation

31 August 2024 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Tricuspid regurgitation and intervention: what are the limits? Tricuspid Valve Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Avi Sabbag

Chaim Sheba Medical Center, Ramat Gan (Israel)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on tricuspid regurgitation and intervention: what are the limits?
Associate Professor F. Praz (Bern, CH)
Slides Video
Presentation thumbnail
The prognostic impact of tricuspid regurgitation improvement after left-sided valvular interventions
Mrs I. Von Der Heide (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Effective RV ejection fraction by CMR: a new index of RV function in patients with severe TR.
Mrs R. Hinojar Baydes (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Improvement of endorgan function following tricuspid edge-to-edge repair
Professor U. Jorde (New York, US)
Abstract Slides Video

Access the full session

Session thumbnail
Tricuspid regurgitation and intervention: what are the limits?
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Progression of atrioventricular valve regurgitation in patients with and without atrial fibrillation
thumbnail
Congress Presentation
Clinical evaluation and optimal medical management of tricuspid regurgitation
thumbnail
Congress Presentation
Impact of atrial fibrillation on progression of tricuspid regurgitation in patients undergoing transcatheter aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources